Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 612-179-8 | CAS number: 61597-98-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The substance was not acutely toxic via the oral or dermal route of exposure.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1984-02-10 to 1984-03-13
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study performed under GLP conditions and similar to OECD guideline 401;
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories Inc., Wilmington, USA
- Age at study initiation: young adults animals
- Weight at study initiation: males: 227.6 to 265.6 g; females: 192.8 to 210.2 g (values given as averages for different dose groups on day 1 of the experiment)
- Fasting period before study: overnight fasting
- Housing: individually in wire mesh bottom cages
- Diet (e.g. ad libitum): NIH open formula 07, Zeigler Brothers, Gardners, USA ad libitum
- Water (e.g. ad libitum): fresh tap water ad libitum
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): not reported
- Humidity (%): not reported
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): not reported - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: not given
- Amount of vehicle (if gavage): substance was adiministered in 10 mL of corn oil
- Justification for choice of vehicle: use of vehicle not justified
- Lot/batch no. (if required): not given
- Purity: not given - Doses:
- Limit test: 5000 mg/kg
Main test: 2000 mg/kg; 2828 mg/kg; 4000 mg/kg; 5657 mg/kg; 8000 mg/kg; 9514 mg/kg - No. of animals per sex per dose:
- Each dose was administered to 5 male and 5 females.
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: twice daily
- Frequency of weighing: on day 1, 8 and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- LD50 values were calculated according to Finney DJ (1971), Statistical methods in biological assays, second edition, London: Griffin Press.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 7 871 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 5 972 - 13 025
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 6 571 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 4 807 - 11 212
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 7 257 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 5 971 - 9 675
- Mortality:
- No mortality of male rats occurred at doses up to 4000 mg/kg, one animal died at 5657 mg/kg, two animals died at 8000 mg/kg and 4 animals died at 9514 mg/kg. No mortality of female rats occurred at 2000 and 4000 mg/kg, one animal died at 2828 mg/kg, two animals died at 5657 and 8000 mg/kg each and all five animals died at 9514 mg/kg.
- Clinical signs:
- other: Observed clinical signs included decreased activity, ataxia, diarrhoea, lacrimation, wet abdomen and salivation.
- Gross pathology:
- Few observations were made during gross pathology including red spots of 1mm diameter on the cortical surface of kidneys (except at 5657 and 9514 mg/kg) and intestines of dark red colour containing blood-like viscous liquid (at 8000 mg/kg).
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- L-Menthyl-Lactate is not acutely toxic via the oral route with a LD50 of 7257 mg/kg body weight. The substance is not classified according to CLP.
- Executive summary:
Frescolat/L-Menthyl Lactate 620105 was evaluated for acute oral toxicity (LD50) in male and female Sprague-Dawley rats. A limit test at 5000 mg/kg bw and a regular test with five dose levels ranging from 2000 to 9514 mg/kg bodyweight were performed. In the latter, five separate solutions of the sample corresponding to five doses were prepared in corn oil immediately prior to administration. All solutions were administered to overnight fasted animals at a volume of 10 mL/kg bodyweight. All animals were observed for mortality and toxic signs at least twice daily, for 14 days. Necropsy was performed with all animals. The calculated acute oral LD50 of the test article in male rats was found to be 7871 mg/kg body weight with a 95% confidence interval of 5972 to 13025 mg/kg. The calculated LD50 for females was found to be 6571 mg/kg body weight with a 95% confidence interval of 4807 to 11212 mg/kg body weight and the combined LD50 was calculated to be 7257 mg/kg body weight with a 95% confidence interval of 5971 to 9675 mg/kg.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 7 257 mg/kg bw
- Quality of whole database:
- The information is considered as reliable with few restrictions.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study was performed under GLP conditions according to OECD and EU guidelines
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Bantin & Klingman Ltd.
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: male: 201-230g, female 200 - 227g
- Fasting period before study: not reported
- Housing: solid-floor polypropylene cages with sawdust bedding
- Diet (e.g. ad libitum):ad libitum
- Water (e.g. ad libitum):ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 - 24°C
- Humidity (%): 40 - 56%
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12h dark / 12 h light - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: skin of the back and flanks, totalling about 10% of the total body surface area
- % coverage: semi-occlusive, not specified
- Type of wrap if used: self-adhesive bandage (HYPERTIE)
REMOVAL OF TEST SUBSTANCE
- Washing (if done): treated skin and surrounding hair was wiped with cotton wool moistened with distilled water
- Time after start of exposure: 24 hours after application following removal of cover
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): not reported
- Concentration (if solution): not applicable
VEHICLE
- no vehicle used - Duration of exposure:
- 24 hours of semi-occlusive skin contact
- Doses:
- 10 g/kg bw of undiluted Menthyl lactate was applied onto skin area of about 4 x 5 cm
- No. of animals per sex per dose:
- 5 male and 5 female rats
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations for overt signs of toxicity and death: 1 and 4 hours after dosing, at least once daily for 14 days
- Body weight: individual body weights were recorded on the day of treatment and on days seven and fourteen
- Necropsy of survivors performed: all animals were subjected to a gross necropsy examination for any macroscopic abnormalities
- Other examinations performed: clinical signs - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 10 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No animal died during the study period.
- Clinical signs:
- other: No evidence of systemic toxicity or skin irritation was noted during the observation period of 14 days.
- Gross pathology:
- No abnormalities were noted at necropsy of animals killed at the end of the study.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute dermal median lethal dose (LD50) of the test material, Menthyl lactate, to Sprague-Dawley rats was found to be greater than 10 g/kg bodyweight. The substance is not classified according to CLP.
- Executive summary:
The acute dermal toxicity of the test material in the Sprague-Dawley rat was determined according to the OECD Guideline for Testing of Chemicals (1981) No. 402 "Acute Dermal Toxicity" with a group of ten animals (five males and five females).
A single, 24-hour, semi-occluded dermal application of the test material to intact skin, at a dose level of 10 g/kg bodyweight was given. Animals were observed for a period of 14 days after application. There were no deaths, no evidence of systemic toxicity or skin irritation and no toxicologically significant effects on bodyweight noted during the study period. Also no abnormalities were noted at necropsy of animals killed at the end of the study.
The acute dermal median lethal dose (LD50) of the test material in the Sprague-Dawley rat was found to be greater than 10 g/kg bodyweight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Quality of whole database:
- The information is considered as reliable without restrictions.
Additional information
Acute toxicity studies with rats are available for the oral and dermal routes of exposure representing also the likely routes of human exposure to menthyl lactate. The substance did not exhibit adverse effects in these two acute toxicity studies. Accordingly, the substance does not exhibit acute oral or dermal toxicity.
Justification for selection of acute toxicity – oral endpoint
This is a valid study on the acute oral toxicity of the substance similar to OECD TG 401 study. The study was performed under GLP.
Justification for selection of acute toxicity – dermal endpoint
This is a valid study on the acute dermal toxicity of the substance according to OECD TG 402. The study was performed under GLP.
Justification for classification or non-classification
- oral toxicity:
Based on the above stated assessment of the acute oral toxicity of menthyl lactate, the results from reliable with restrictions study are above the threshold value given in the CLP Regulation. Therefore menthyl lactate does not need to be classified according to Council Directive 2001/59/EC (28th ATP of Directive 67/548/EEC) and according to CLP (Regulation (EC) No 1272/2008 of the European Parliament and of the Council) as implementation of UN-GHS in the EU.
- dermal toxicity:
Based on the above stated assessment of the acute dermal toxicity, menthyl lactate does not need to be classified according to Council Directive 2001/59/EC (28th ATP of Directive 67/548/EEC) and according to CLP (Regulation (EC) No 1272/2008 of the European Parliament and of the Council) as implementation of UN-GHS in the EU.
- inhalation toxicity:
No inhalation studies are available and due to exposure considerations the conduct of studies and the classification and labelling for this endpoint is deemed not to be necessary.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.